These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9187909

  • 1. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
    Skopelitou A, Hadjiyannakis M, Dimopoulos D, Kamina S, Krikoni O, Alexopoulou V, Rigas C, Agnantis NJ.
    Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H, Igawa M, Nagami H, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T, Kawanishi M.
    Cancer; 1996 Oct 15; 78(8):1762-74. PubMed ID: 8859190
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemistry of p53 protein in transitional-cell carcinoma of the bladder using an image analyzer.
    Shiina H, Igawa M, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T.
    Oncology; 1996 Oct 15; 53(3):233-40. PubMed ID: 8643227
    [Abstract] [Full Text] [Related]

  • 9. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
    Lee CC, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, Nakatani T, Wada S, Kishimoto T, Fukushima S.
    Cancer; 1997 Feb 15; 79(4):780-9. PubMed ID: 9024716
    [Abstract] [Full Text] [Related]

  • 10. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P, Christodoulou P, Kapralos P, Exarchakos M, Bisbiroula A, Hadjiyannakis M, Georgountzos C, Thomas-Tsagli E.
    Pathol Res Pract; 1997 Feb 15; 193(11-12):767-75. PubMed ID: 9521509
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L, Constantinides C, Papandropoulos J, Theodoropoulos G, Tzonou A, Giannopoulos A, Zervas A, Dimopoulos C.
    Urology; 1995 Sep 15; 46(3):334-40. PubMed ID: 7660508
    [Abstract] [Full Text] [Related]

  • 12. Numeric aberration of chromosome 17 is strongly correlated with p53 overexpression, tumor proliferation and histopathology in human bladder cancer.
    Li B, Kanamaru H, Noriki S, Fukuda M, Okada K.
    Int J Urol; 1998 Jul 15; 5(4):317-23. PubMed ID: 9712438
    [Abstract] [Full Text] [Related]

  • 13. Biological characteristics of inverted papilloma of the urinary bladder.
    Urakami S, Igawa M, Shirakawa H, Shiina H, Ishibe T.
    Br J Urol; 1996 Jan 15; 77(1):55-60. PubMed ID: 8653317
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity.
    Ogura K, Habuchi T, Yamada H, Ogawa O, Yoshida O.
    Int J Urol; 1995 Nov 15; 2(5):302-8. PubMed ID: 8749948
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Expression of P21, p53 and proliferating cell nuclear antigen in human bladder cancer].
    Ding Q, Zhang Y, Sun X.
    Zhonghua Bing Li Xue Za Zhi; 1997 Aug 15; 26(4):211-3. PubMed ID: 10072865
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder].
    Kuczyk MA, Serth J, Bokemeyer C, Hervatin C, Oelke M, Oelert F, Höfner K, Jonas U.
    Urologe A; 1995 Mar 15; 34(2):146-52. PubMed ID: 7754587
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.